Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy

Am J Ophthalmol. 2014 May;157(5):1048-55. doi: 10.1016/j.ajo.2014.01.020. Epub 2014 Jan 30.

Abstract

Purpose: To evaluate the effects of epiretinal membranes on the response of uveitic macular edema to therapy and on visual acuity outcomes.

Design: Retrospective case series.

Methods: One hundred four eyes of 77 patients with uveitic macular edema were identified at a tertiary care center. Epiretinal membranes were diagnosed when identified by 2 investigators' grading of spectral-domain optical coherence tomography and scored for the presence or absence of surface wrinkling. Outcomes included best-corrected visual acuity, central subfield thickness, and rates of macular edema improvement (>20% reduction in central subfield thickness) and resolution (reduction of central subfield thickness to <315 μm) at 3 and 6 months follow-up.

Results: Seventy-two eyes of 59 patients had an epiretinal membrane on presentation. Eyes without epiretinal membranes and with epiretinal membranes without surface wrinkling were not significantly different at presentation or at 3 and 6 months follow-up. Conversely, eyes with an epiretinal membrane with retinal surface wrinkling had a greater proportion of eyes with 20/200 or worse visual acuity at presentation, and had worse mean acuities at 3 months (20/94 vs 20/35 for eyes without an epiretinal membrane, P = .002) and at 6 months follow-up (20/110 vs 20/36 for eyes without an epiretinal membrane, P = .02). At 6 months of follow-up the mean central subfield thicknesses were: eyes without an epiretinal membrane, 338 ± 23 μm; and eyes with an epiretinal membrane and surface wrinkling, 405 ± 22 μm (P = .05).

Conclusions: In eyes with epiretinal membranes and retinal surface wrinkling, uveitic macular edema had a poorer visual acuity response to medical therapy and thicker maculae at 6 months.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Epiretinal Membrane / diagnosis
  • Epiretinal Membrane / physiopathology*
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Intravitreal Injections
  • Macular Edema / diagnosis
  • Macular Edema / drug therapy
  • Macular Edema / physiopathology*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Uveitis / diagnosis
  • Uveitis / drug therapy
  • Uveitis / physiopathology*
  • Vision Disorders / diagnosis
  • Vision Disorders / drug therapy
  • Vision Disorders / physiopathology*
  • Visual Acuity / physiology*

Substances

  • Glucocorticoids
  • Immunosuppressive Agents